stock market

CELZ stock forecast 2025: CELZ stock price Target 2022 Celz Stock Message Board

Advertisements

CELZ stock

Table of Contents

Celz Stock Message Board ,stock celz celz stocktwits celz stock price celz stock forecast , celz stock forecast 2025, stock celz, celz price target

CELZ  stock forecast 2025

Basically, CELZ Creative Medical Technology Holdings Inc. COMPANY are Doing a best in medical field and company are treament of Urology Methods for Treatment of Premature Ovarian Failure and Ovarian Aging Using Regenerative Cells Urology Treatment of Erectile Dysfunction by Stem Cell Therapy

IPL 2022 ALL NEW TEAMS LIST WITH PLAYERS

CELZ STOCK FORCAST 2025

MULTIBAGGER PENNY STOCKS FOR 2025 BELOW 2 RUPEES

 MULTIBAGGER PENNY STOCKS FOR 2022

CELZ Creative Medical Technology Holdings Inc. COMPANY, Urology Methods of Treating Erectile Dysfunction Using Regenerative Cells and Therapeutic Energy Treatments Neuro/Oncology Treatment of Glioma by Amniotic Fluid Stem Cells and Exosomes Derived Thereof Neurology Generation of Autologous Immune Modulatory Cells for Treatment of Neurological Conditions Stem Cells Multipotent Amniotic Fetal Stem Cells.

Celz Stock Message Board

CELZ Creative Medical Technology Holdings Inc. COMPANY, Orthopedics Enhancement of Nucleus Pulposus Regeneration by Enhanced Perfusion of Perispinal Area by Combination Drug, Gene and Cellular Therapies Orthopedics Perispinal Perfusion by Administration of T Regulatory Cells Alone or in Combination with Angiogenic Cell Therapies.

CELZ stock forecast 2025

CELZ stock

celz stock CELZ Creative Medical Technology Holdings Inc. FUNDAMENTAL

 Current Market Price1.57USD$
Market Capital99.34L$
Earnings per share (EPS)
Price-Earning Ratio (PE)
Industry PE
52WEEK HIGH34.50$
52WEEK LOW1.32$
No. of Shares Subscribed

CELZ Creative Medical Technology Holdings Inc. COMPANY, Orthopedics Treatment of Disc Degenerative Disease Immunotherapy Induction of Infectious Tolerance by Ex Vivo Reprogrammed Immune Cells Immunotherapy Generation of Autologous Immune Modulatory Cells for Treatment of Neurological Conditions.

CELZ stock forecast 2025

CELZ Creative Medical Technology Holdings Inc. celz stock

TIME PERIODcelz stock  RETURN IN PAST
5YEAR-99%
1YEAR-93%
6 MONTH-87%
3 MONTH-32%
1 MONTH-10%
1WEEK-7%

CELZ Creative Medical Technology Holdings Inc. COMPANY, Immunotherapy Treatment of Heart Failure and/or Post Infarct Pathological Remodeling by Ex Vivo Reprogrammed Immune Cells Immunotherapy Treatment of Diabetes Using Immune Cells Reprogrammed Ex Vivo by Regenerative Cells.

CELZ stock forecast 2025

Immunotherapy Treatment of Liver Failure by Ex Vivo Reprogrammed Immune Cells,Treatment of Chronic Rejection and Concurrent Induction of Transplantation Tolerance by Ex Vivo Altered Immune Cells.

Celz Stock Message Board

UrologyMethods for Treatment of Premature Ovarian Failure and Ovarian Aging Using Regenerative Cells Celz Stock Message Board
UrologyTreatment of Erectile Dysfunction by Stem Cell Therapy
UrologyMethods of Treating Erectile Dysfunction Using Regenerative Cells and Therapeutic Energy Treatments Celz Stock Message Board
Neuro/OncologyTreatment of Glioma by Amniotic Fluid Stem Cells and Exosomes Derived Thereof
NeurologyGeneration of Autologous Immune Modulatory Cells for Treatment of Neurological Conditions
Stem CellsMultipotent Amniotic Fetal Stem Cells
OrthopedicsEnhancement of Nucleus Pulposus Regeneration by Enhanced Perfusion of Perispinal Area by Combination Drug, Gene and Cellular Therapies Celz Stock Message Board
OrthopedicsPerispinal Perfusion by Administration of T Regulatory Cells Alone or in Combination with Angiogenic Cell Therapies
OrthopedicsTreatment of Disc Degenerative Disease
ImmunotherapyInduction of Infectious Tolerance by Ex Vivo Reprogrammed Immune Cells CELZ stock forecast 2025
ImmunotherapyGeneration of Autologous Immune Modulatory Cells for Treatment of Neurological Conditions
ImmunotherapyTreatment of Heart Failure and/or Post Infarct Pathological Remodeling by Ex Vivo Reprogrammed Immune CellsCELZ stock forecast 2025
ImmunotherapyTreatment of Diabetes Using Immune Cells Reprogrammed Ex Vivo by Regenerative Cells
ImmunotherapyTreatment of Liver Failure by Ex Vivo Reprogrammed Immune CellsCELZ stock forecast 2025
ImmunotherapyTreatment of Chronic Rejection and Concurrent Induction of Transplantation Tolerance by Ex Vivo Altered Immune Cells

Leave a Reply

Your email address will not be published.